Sg Americas Securities, LLC Akero Therapeutics, Inc. Transaction History
Sg Americas Securities, LLC
- $24.4 Billion
- Q4 2024
A detailed history of Sg Americas Securities, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 597,993 shares of AKRO stock, worth $15 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
597,993
Previous 14,507
4022.1%
Holding current value
$15 Million
Previous $416,000
3899.04%
% of portfolio
0.07%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding AKRO
# of Institutions
190Shares Held
74.4MCall Options Held
241KPut Options Held
647K-
Wellington Management Group LLP Boston, MA7.9MShares$199 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X07.08MShares$178 Million0.11% of portfolio
-
Rtw Investments, LP New York, NY5.92MShares$149 Million2.71% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$140 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$132 Million4.29% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.17B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...